MX370715B - Vacuna de subunidades anti-mycoplasma spp. - Google Patents

Vacuna de subunidades anti-mycoplasma spp.

Info

Publication number
MX370715B
MX370715B MX2017014670A MX2017014670A MX370715B MX 370715 B MX370715 B MX 370715B MX 2017014670 A MX2017014670 A MX 2017014670A MX 2017014670 A MX2017014670 A MX 2017014670A MX 370715 B MX370715 B MX 370715B
Authority
MX
Mexico
Prior art keywords
mycoplasma spp
vaccine
proteins
subunit vaccine
active ingredient
Prior art date
Application number
MX2017014670A
Other languages
English (en)
Inventor
Jiunn-Horng Lin
Jyh-Perng Wang
Ming-Wei Hsieh
Zeng-Weng Chen
Chien-Yu Fang
Hsueh-Tao Liu
Ping-Cheng Yang
Original Assignee
Agricultural Tech Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Tech Res Inst filed Critical Agricultural Tech Res Inst
Publication of MX370715B publication Critical patent/MX370715B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a vacunas de subunidades anti-Mycoplasma spp., especialmente proteínas adecuadas para que sean usadas como el ingrediente activo de las vacunas de subunidades de Mycoplasma spp., y una vacuna preparada de las mismas; tras la experimentación, se confirma que las proteínas pueden inducir una respuesta inmune que tiene resistencia suficiente para evitar la infección por Mycoplasma spp. en cerdos; la vacuna puede comprender una de las proteínas mencionadas anteriormente como un ingrediente activo, o puede comprender dos o más de las proteínas para formar una forma de vacuna coctel; la vacuna de la presente invención no es sólo más segura que las vacunas convencionales, sino tiene también efectos inmunes equivalentes o incluso mejores.
MX2017014670A 2013-02-05 2013-02-05 Vacuna de subunidades anti-mycoplasma spp. MX370715B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/071379 WO2014121433A1 (zh) 2013-02-05 2013-02-05 抗霉浆菌的亚单位疫苗

Publications (1)

Publication Number Publication Date
MX370715B true MX370715B (es) 2019-12-20

Family

ID=51299148

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017014670A MX370715B (es) 2013-02-05 2013-02-05 Vacuna de subunidades anti-mycoplasma spp.
MX2015010102A MX355078B (es) 2013-02-05 2013-02-05 Vacuna de subunidades anti-mycoplasma spp.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2015010102A MX355078B (es) 2013-02-05 2013-02-05 Vacuna de subunidades anti-mycoplasma spp.

Country Status (14)

Country Link
US (7) US9561267B2 (es)
EP (3) EP2955192B1 (es)
JP (1) JP6113306B2 (es)
KR (7) KR101764750B1 (es)
CN (1) CN104918953B (es)
BR (1) BR112015018444A2 (es)
DK (1) DK2955192T3 (es)
ES (1) ES2812552T3 (es)
MX (2) MX370715B (es)
PH (1) PH12015501716A1 (es)
RU (1) RU2636459C2 (es)
TW (1) TWI609878B (es)
UA (2) UA116431C2 (es)
WO (1) WO2014121433A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX368864B (es) * 2013-11-21 2019-10-18 Agricultural Tech Res Inst Composicion para prevenir infeccion por mycoplasma spp.
AU2015287993B2 (en) * 2014-07-07 2020-10-29 Liferaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
CN106139137A (zh) * 2015-03-30 2016-11-23 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
WO2017011919A1 (en) * 2015-07-22 2017-01-26 University Of Saskatchewan Mycoplasma vaccines and uses thereof
US10767185B2 (en) * 2015-12-28 2020-09-08 Agricultural Technology Research Institute Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same
TWI606839B (zh) * 2016-08-09 2017-12-01 財團法人農業科技研究院 防治豬鼻黴漿菌感染之組合物及生產該組合物的方法
EP3778626A1 (en) * 2016-08-09 2021-02-17 Agricultural Technology Research Institute Composition for preventing and treating mycoplasma hyorhinis infection, and method for producing said composition
JP7082196B2 (ja) * 2017-11-01 2022-06-07 アグリカルチュラル テクノロジー リサーチ インスティテュート マイコプラズマ・シノビエ感染を予防または治療するための組成物
RU2737971C1 (ru) * 2020-05-22 2020-12-07 Эгрикалчурал Текнолоджи Рисерч Инститьют Композиция для профилактики и лечения инфекции mycoplasma hyorhinis и способ получения указанной композиции

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0359919B1 (en) * 1988-06-29 1996-02-28 Ml Technology Ventures, L.P. Recombinant mycoplasma hyopneumoniae antigen and uses therefor
EP0571648A1 (en) * 1992-05-26 1993-12-01 Chung-Nan Weng Vaccine protecting against mycoplasmal pneumonia
EP0603406B1 (en) * 1992-05-29 2001-09-19 Nippon Zeon Co., Ltd. Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same
DE19816334A1 (de) 1998-04-11 1999-10-14 Krupp Uhde Gmbh Elektrolyseapparat zur Herstellung von Halogengasen
AU6128900A (en) 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6537552B1 (en) 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
CZ305781B6 (cs) * 2001-07-02 2016-03-16 Zoetis Services Llc Výroba vakcíny Mycoplasma hyopneumoniae
WO2005003313A2 (en) * 2003-06-26 2005-01-13 Lifesensors, Inc. Methods and compositions for enhanced protein expression and purification
BR0306775A (pt) * 2003-12-23 2005-10-04 Conselho Nacional Cnpq Polinucleotìdeos codificadores de atividades do cromossomo da bactéria mycoplasma hyopneumoniae
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
TW200951219A (en) 2008-05-06 2009-12-16 Academia Sinica An improved SUMO fusion protein system for effective production of native proteins
EP2398486A4 (en) * 2009-02-20 2012-11-21 Cdg Therapeutics Inc Compositions and methods for preventing and / or treating cancer by pa-card
CN101638435B (zh) * 2009-09-04 2011-11-16 暨南大学 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用

Also Published As

Publication number Publication date
US9757441B2 (en) 2017-09-12
KR20150107767A (ko) 2015-09-23
KR101831318B1 (ko) 2018-02-22
WO2014121433A1 (zh) 2014-08-14
PH12015501716B1 (en) 2015-11-09
KR20170082656A (ko) 2017-07-14
DK2955192T3 (en) 2020-08-17
KR101758778B1 (ko) 2017-07-18
MX2015010102A (es) 2016-04-27
US20170182142A1 (en) 2017-06-29
CN104918953A (zh) 2015-09-16
US20150366959A1 (en) 2015-12-24
US20170196959A1 (en) 2017-07-13
UA115348C2 (uk) 2017-10-25
TWI609878B (zh) 2018-01-01
US9750791B2 (en) 2017-09-05
JP2016514086A (ja) 2016-05-19
JP6113306B2 (ja) 2017-04-12
US9730990B2 (en) 2017-08-15
KR101775434B1 (ko) 2017-09-06
US9750790B2 (en) 2017-09-05
RU2636459C2 (ru) 2017-11-23
MX355078B (es) 2018-04-03
KR101773486B1 (ko) 2017-08-31
EP2955192A4 (en) 2016-11-23
RU2015137851A (ru) 2017-03-14
TW201431873A (zh) 2014-08-16
KR101775435B1 (ko) 2017-09-06
BR112015018444A2 (pt) 2018-05-08
US9561267B2 (en) 2017-02-07
KR20170081759A (ko) 2017-07-12
EP3733691A1 (en) 2020-11-04
US20170202942A1 (en) 2017-07-20
US9775893B2 (en) 2017-10-03
PH12015501716A1 (en) 2015-11-09
EP3733690A1 (en) 2020-11-04
ES2812552T3 (es) 2021-03-17
US20170151318A1 (en) 2017-06-01
KR101764750B1 (ko) 2017-08-03
US20170182144A1 (en) 2017-06-29
KR20170082657A (ko) 2017-07-14
US9750792B2 (en) 2017-09-05
EP2955192B1 (en) 2020-07-01
EP2955192A1 (en) 2015-12-16
KR101838160B1 (ko) 2018-03-13
KR20170081760A (ko) 2017-07-12
KR20170081758A (ko) 2017-07-12
UA116431C2 (uk) 2018-03-12
US20170182143A1 (en) 2017-06-29
CN104918953B (zh) 2019-04-02
KR20170081757A (ko) 2017-07-12

Similar Documents

Publication Publication Date Title
PH12015501716A1 (en) Anti-mycoplasma spp. subunit vaccine
PH12018500127A1 (en) Vaccine compositions
PH12017502233A1 (en) Formulations for neoplasia vaccines and methods of preparing thereof
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
MX2017009308A (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
MX2022002106A (es) Formulaciones de vacuna de vial unico.
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
SG11202003796XA (en) Zika vaccines and immunogenic compositions, and methods of using the same
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
NZ630831A (en) Compositions and methods for administration of vaccines against dengue virus
MX2021013109A (es) Proceso de preparacion de una vacuna tetravalente atenuada contra el virus del dengue.
MX2022013912A (es) Procedimientos novedosos para inducir una respuesta inmunitaria.
PH12014501795A1 (en) Rota virus subunit vaccines and methods of making and use thereof
MX2016002823A (es) Metodos y composiciones para vacunas vectorizadas virales.
ZA201602148B (en) Immunogenic formulation containing recombinant live bcg that express antigens of metapneumovirus (hmpv), in a suspension prepared from a lyophilisate, without requiring an adjuvant, suitable for pharmaceutical use
EA201690378A1 (ru) Вакцинные композиции против наркотической зависимости
WO2013173256A3 (en) New and improved influenza vaccines
MX2019015700A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015698A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015697A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015695A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015696A (es) Vacuna de subunidades anti-mycoplasma spp.